ASO Author Reflections: Advancing Gastric Cancer Treatment Through HIPEC—Current Insights and Future Directions Ying ChenYang ZhouShoushan Li ASO Author Reflections 28 October 2024 Pages: 252 - 253
ASO Visual Abstract: Triphasic Learning Curve of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Yusuf CiftciShannon N. RadomskiJonathan B. Greer ASO Visual Abstract 24 October 2024 Pages: 254 - 254
ASO Visual Abstract: Insight into Predictors of Cytoreduction Score Following Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy for Gastric Peritoneal Carcinomatosis Improves Patient Selection and Prognostic Outcomes Ahmed B. HamedRudy El AsmarSamer S. AlMasri ASO Visual Abstract 02 November 2024 Pages: 255 - 256
ASO Visual Abstract: Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): Cancer Survivors’ Perspective Through in-Depth Interviews Luis Felipe Falla-ZunigaMary Caitlin KingArmando Sardi ASO Visual Abstract 06 November 2024 Pages: 257 - 257
The Impact of Diagnostic Laparoscopy on Upstaging Patients with Siewert II and III Gastroesophageal Junction (GEJ) Cancer Nathan J. AlcasidDeanna FinkJeffrey B. Velotta Thoracic Oncology Open access 06 November 2024 Pages: 258 - 264
The Optimal Time of High-Intensity Pre-rehabilitation for Surgical Lung Cancer Patients: A Retrospective Cohort Study with 4452 Patients Yutian LaiYingxian DongGuowei Che Thoracic Oncology 19 September 2024 Pages: 265 - 273
Safety and Efficacy of Conversion Therapy After Systemic Chemotherapy in Advanced Esophageal Cancer with Distant Metastases: A Multicenter Retrospective Observational Study Takayuki TsujiSatoru MatsudaHirofumi Kawakubo Thoracic Oncology 12 September 2024 Pages: 274 - 283
Endobronchial Ultrasonography to Assess and Evaluate Tracheobronchial Tree Invasion in cT4b Esophageal Cancer Patients Treated with Definitive Chemoradiotherapy: Assessment of Resectability I. L. DefizeE. M. de GrootR. van Hillegersberg Thoracic Oncology Open access 06 July 2024 Pages: 284 - 292
Prognostic Impact of Thoracic Duct Resection in Patients Who Underwent Transthoracic Esophagectomy Following Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma: Exploratory Analysis of JCOG1109 Satoru MatsudaHiroya TakeuchiYuko Kitagawa Thoracic Oncology and Esophageal Cancer 07 October 2024 Pages: 293 - 301
Phase II Trial of Adjuvant S-1 Following Neoadjuvant Chemotherapy and Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: The PIECE Trial Motoo NomuraToshifumi YamaguchiManabu Muto Thoracic Oncology and Esophageal Cancer Open access 07 October 2024 Pages: 302 - 311
Comparative Analyses of the Outcomes Between Lobectomies and Trisegmentectomies/Lingulectomies in the Surgical Management of Clinical Stage I Left Upper Lobe Non-small Cell Lung Cancer Tzu-Ning KaoXu-Heng ChiangJin-Shing Chen Thoracic Oncology and Esophageal Cancer 24 October 2024 Pages: 312 - 323
Classic and Visceral-Sparing Complete Pelvic Peritonectomy for Peritoneal Surface Malignancies: A Video Demonstration in Female Patients Julian Henao ArdilaDomenico SabiaLana Bijelic Thoracic Oncology and Esophageal Cancer 10 October 2024 Pages: 324 - 324
ASO Author Reflections: Can Conversion Therapy be an Option for Advanced Esophageal Cancer with Distant Metastases? Takayuki TsujiSatoru MatsudaHirofumi Kawakubo ASO Author Reflections 01 October 2024 Pages: 325 - 326
ASO Author Reflections: Should we Change the Indication for Thoracic Duct Resection Based on the Response to Neoadjuvant Chemotherapy? Satoru MatsudaHiroya TakeuchiYuko Kitagawa ASO Author Reflections 28 October 2024 Pages: 327 - 328
ASO Visual Abstract: The Impact of Diagnostic Laparoscopy on Upstaging Patients with Siewert II and III Gastroesophageal Junction (GEJ) Cancer Nathan J. AlcasidDeanna FinkJeffrey B. Velotta ASO Visual Abstract 06 November 2024 Pages: 329 - 330
ASO Visual Abstract: Comparative Analyses of the Outcomes Between Lobectomies and Trisegmentectomies/Lingulectomies in the Surgical Management of Clinical Stage I Left Upper Lobe Non-small Cell Lung Cancer Tzu-Ning KaoXu-Heng ChiangJin-Shing Chen ASO Visual Abstract 31 October 2024 Pages: 331 - 332
Enhancing Preoperative Diagnosis Accuracy of Stage III Gastric Cancer with Circulating circRNAs Koichi MatsutokaKatsutoshi ShodaDaisuke Ichikawa Gastrointestinal Oncology 21 October 2024 Pages: 333 - 341
Downstaging Effect Rather than the Full Intended Cycles of Perioperative Chemotherapy Determines the Value of Adjuvant Chemotherapy in Gastric Cancer Zefeng LiChongyuan SunChunxia Du Gastrointestinal Oncology 24 October 2024 Pages: 342 - 350
Robotic Versus Laparoscopic Gastrectomy for Gastric Cancer: The Largest Systematic Reviews of 68,755 Patients and Meta-analysis Rui DuYue WanGuofang Lu Gastrointestinal Oncology 17 October 2024 Pages: 351 - 373
ASO Author Reflections: Robotic and Laparoscopic Gastrectomy Comparison Rui DuGuofang Lu ASO Author Reflections 24 October 2024 Pages: 374 - 375
ASO Visual Abstract: Changes in Skeletal Muscle Mass in the First 3 Months Following Gastrointestinal Cancer Surgery: A Prospective Study Xinyi XuWei-Hong LiuPatsy Yates ASO Visual Abstract 16 October 2024 Pages: 376 - 377
Letter to the Editor: Circulating Exosomal MicroRNA Signature Predicts Peritoneal Metastasis in Patients with Advanced Gastric Cancer Jiaqing WangYi Qin Gastrointestinal Oncology 07 October 2024 Pages: 378 - 379
Reply: Circulating Exosomal MicroRNA Signature Predicts Peritoneal Metastasis in Patients with Advanced Gastric Cancer Yuma WadaMasaaki NishiMitsuo Shimada Gastrointestinal Oncology 01 November 2024 Pages: 380 - 381
Essential Elements in Synoptic Operative Reports for Hepato-Pancreato-Biliary Cancer Surgery: An HPB/CGSO Training Program Survey Lyonell B. KoneDavid SeokMichael Jacobs Hepatobiliary Tumors 30 September 2024 Pages: 382 - 390
The Role of Metastasectomy in Patients with Liver-Only Metastases from Gastric Adenocarcinoma Ioannis A. ZiogasOtto N. ThielenBenedetto Mungo Hepatobiliary Tumors 30 September 2024 Pages: 391 - 398
Association of the Number of Concurrent Metabolic Syndrome Risk Factors with Textbook Outcomes Following Liver Resection for Patients with Hepatocellular Carcinoma: A Multicenter Study Zhan-Cheng QiuJun-Long DaiChuan Li Hepatobiliary Tumors 07 October 2024 Pages: 399 - 407
Evaluating Combinations of Biological and Clinicopathologic Factors Linked to Poor Outcomes in Resected Colorectal Liver Metastasis: An External Validation Study Kazunari SasakiJane WangGeorgios Antonios Margonis Hepatobiliary Tumors 08 October 2024 Pages: 408 - 417
Observed Changes in the Distribution of Colon Cancer Metastasis: A National Cancer Database Review and Institutional Experience Kyle R. StephensWalter R. F. DonicaRobert C. G. Martin II Hepatobiliary Tumors 08 October 2024 Pages: 418 - 423
Portal Vein Arterialization as a Lifesaving Strategy for Hepatic Artery Injury in Robotic Hepatectomy Yan LiAnlan ZhangBaoyong Zhou Hepatobiliary Tumors 10 October 2024 Pages: 424 - 425
Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular Carcinoma Frances J. BennettJessica M. KeilsonShishir K. Maithel Hepatobiliary Tumors 16 October 2024 Pages: 426 - 437
Robotic Hepatic Parenchymal Transection Techniques: A Choice Between Imperfect Tools Jace LandryAnish J. JainHop S. Tran Cao Hepatobiliary Tumors 16 October 2024 Pages: 438 - 439
Exploring the Potential of Robotic Single-Port Surgery for Gallbladder Cancer: Initial Insights and Future Prospects Eun Jeong JangKwan Woo Kim Hepatobiliary Tumors 17 October 2024 Pages: 440 - 442
How to Find Correct Transection Plane in Laparoscopic Right Hepatectomy Extended to S1 for Bismuth IIIa Perihilar Cholangiocarcinoma Serena ArmentanoJosé Miguel AcevesSantiago Lopez-Ben Hepatobiliary Tumors 27 September 2024 Pages: 443 - 445
ASO Author Reflections: Liver Metastasectomy for Gastric Adenocarcinoma Ioannis A. ZiogasBenedetto Mungo ASO Author Reflections 28 October 2024 Pages: 446 - 447
ASO Author Refections: The potential role of particle therapy as a therapeutic option for patients with recurrent hepatocellular carcinoma after liver resection Tatsuki KusuharaHidetoshi GonTakumi Fukumoto ASO Author Reflections 26 October 2024 Pages: 448 - 449
ASO Author Reflections: Biological Contraindications to Surgery in Colorectal Liver Metastasis Kazunari SasakiTimothy M. PawlikGeorgios Antonios Margonis ASO Author Reflections 23 October 2024 Pages: 450 - 451
ASO Author Reflections: Achievements of Textbook Outcomes for Hepatocellular Carcinoma Patients After Liver Resection: The Role of the Number of Metabolic Syndrome Risk Factors Zhan-Cheng QiuChuan Li ASO Author Reflections 28 October 2024 Pages: 452 - 453
ASO Visual Abstract: Evaluating Combinations of Biological and Clinicopathologic Factors Linked to Poor Outcomes in Resected Colorectal Liver Metastasis: An External Validation Study Kazunari SasakiJane WangGeorgios Antonios Margonis ASO Visual Abstract 09 November 2024 Pages: 454 - 455
ASO Visual Abstract: Hepatic Resection as the Primary Treatment Modality for Hepatocellular Carcinoma Following Orthotopic Liver Transplantation Abraham J. MatarKailey M. OppatShishir K. Maithel ASO Visual Abstract 26 October 2024 Pages: 456 - 457
ASO Visual Abstract: Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular Carcinoma Frances J. BennettJessica M. KeilsonShishir K. Maithel ASO Visual Abstract 29 October 2024 Pages: 458 - 459
ASO Visual Abstract: Anatomical Versus Non-anatomical Liver Resection for Intrahepatic Cholangiocarcinoma: A Systematic Review and Patient-Level Meta-analysis Giammauro BerardiLuca RisiLuca Viganò ASO Visual Abstract 30 October 2024 Pages: 460 - 461
ASO Visual Abstract: The Role of Metastasectomy in Patients with Liver-Only Metastases from Gastric Adenocarcinoma Ioannis A. ZiogasOtto N. ThielenBenedetto Mungo ASO Visual Abstract 09 November 2024 Pages: 462 - 463
Merkel Cell Polyomavirus Antibody in Tumor and Plasma Specimens in Patients with Merkel Cell Carcinoma Ryan K. SchmockerLaurentia NoditLaura M. Enomoto Melanoma 07 October 2024 Pages: 464 - 473
Are Positive Biopsy Margins in Melanoma Significant?: A Cohort Study of Micro- Versus Macroscopic Margin Status and Their Impact on Residual Disease and Survival Alex LeeBoaz WongCarolyn Nessim Melanoma and Cutaneous Oncology 09 October 2024 Pages: 474 - 481
Genetic Factors Associated with Clinical Response in Melanoma Patients Treated with Talimogene Laherparapvec: A Single-Institution Retrospective Analysis Kailan Sierra-DavidsonAikaterini DedeiliaSonia Cohen Melanoma and Cutaneous Oncology Open access 18 October 2024 Pages: 482 - 494
ASO Author Reflections: Impact of Merkel Cell Polyomavirus Antibody in Tumor and Plasma Specimens Ryan K. SchmockerLaura M. Enomoto ASO Author Reflections Open access 28 October 2024 Pages: 495 - 496
ASO Author Reflections: Optimizing Line of Therapy with the Melphalan/Hepatic Delivery System for Metastatic Uveal Melanoma Helana GhaliMichelle M. DuganJonathan S. Zager ASO Author Reflections 28 August 2024 Pages: 497 - 498
ASO Visual Abstract: Using Nomograms Wisely—Predicting Sentinel Node Positivity in Melanoma Priscila Rojas-GarciaBryan MaClaire Temple-Oberle ASO Visual Abstract Open access 21 September 2024 Pages: 499 - 500
ASO Visual Abstract: Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion as First- or Second-Line Therapy for Metastatic Uveal Melanoma Helana GhaliMichelle M. DuganJonathan S. Zager ASO Visual Abstract 08 October 2024 Pages: 501 - 502
Methodological Concerns Regarding: “Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?” Magnus Glindvad Ahlström Melanoma 17 August 2024 Pages: 503 - 504
